NHI.no
Annonse
Informasjon, veiviser

Hoste - hva kan årsaken være?

Hoste er vanlig under og etter ordinære luftveisinfeksjoner. Oftest er dette tørrhoste. Varer hosten i mer enn åtte uker, betegnes det som kronisk hoste.

Hoste og flimmerhår er viktige faktorer som beskytter luftveiene mot sykdom.

Sist oppdatert:

25. mai 2023

Dette dokumentet er basert på det profesjonelle dokumentet Hoste . Referanselisten for dette dokumentet vises nedenfor

  1. Michaudet C, Malaty J. Chronic Cough: Evaluation and Management. Am Fam Physician. 2017 Nov 1;96(9):575-580. PMID: 29094873. PubMed
  2. Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet 2008;371:1364-1374. PubMed
  3. Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 2020; 55: 1901136. pmid:31515408 PubMed
  4. Kahrilas PJ, Altman KW, Chang AB, et al. Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report. Chest. 2016;150:1341-60. PubMed
  5. Little P, Rumsby K, Kelly J et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. JAMA 2005; June Vol.293(24): 3029-35. pmid:15972565. PubMed
  6. Fahim A, Morice AH. Heightened cough sensitivity secondary to latanoprost. Chest 2009; 136: 1406–1407. PMID: 19892680 PubMed
  7. Malterud K, Reitan R. Nevrogen hoste - en kasuistikk om vellykket behandling med gabapentin . Utposten 2023; 1: 10-11. PubMed
  8. Altiner A, Wilm S, Däubener W et al. Sputum colour for diagnosis of a bacterial infection in patients with acute cough. Scand J Prim Health Care 2009; 27: 70-3. PubMed
  9. van der Meer V, Knuistingh Neven A, van den Broek PJ, Assendelft WJJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ 2005; 331: 26-9. British Medical Journal
  10. Norsk barnelegeforening. Gjør kloke valg. Siden besøkt 26.02.2021. www.legeforeningen.no
  11. Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database of Systematic Reviews 2014, Issue 11. Art. No.: CD001831. DOI: 10.1002/14651858.CD001831.pub5. DOI
  12. Oduwole O, Udoh EE, Oyo-Ita A, et al. Honey for acute cough in children. Cochrane Database Syst Rev. 2018 Dec 23;12:CD007094. doi: 10.1002/14651858.CD007094.pub5. DOI
  13. Bolser DC. Cough Suppressant and Pharmacologic Protussive Therapy: ACCP Evidence-Based Clinical Practice Guidelines. Chest 2006; 129: 238S-249S. doi:10.1378/chest.129.1_suppl.238S
  14. Brenden R, Dahle KMH. Hostedempende opioider som Cosylan og Solvipect comp til barn?. Utposten 2020. www.utposten.no
  15. Becker LA, Hom J, Villasis-Keever M, et al. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. Cochrane Database Syst Rev. 2015 ;9:CD001726. DOI: 10.1002/14651858.CD001726.pub5 DOI
  16. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 2012 Aug 27. pmid:22951084. PubMed
  17. Ribeiro M, Pereira CA, Nery LE, Beppu OS, Silva CO. High-dose inhaled beclomethasone treatment in patients with chronic cough: a randomized placebo-controlled study. Ann Allergy Asthma Immunol 2007; 99: 61-8. PubMed
  18. HcGarvey LP, Birring SS, Morice AH, et al. Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials. Lancet 2022. pmid:35248186 PubMed
Annonse
Annonse